Ekso Bionics (EKSO) Misses Q2 EPS by 3c

Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.4 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Creatd files Form S-1 and reports Q1 2026 financial results
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen